Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Whos at Highest Risk for GLP-1-Related Bone Loss
A large study of more than 3,500 pregnancies found that first-trimester exposure to #GLP-1 receptor agonists was not associated with a substantial increase in pregnancy loss, major congenital anomalies, or abnormal fetal growth
Important safety information: These medications carry a boxed warning for risk of thyroid C-cell tumors and are contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Why is a Pharmacy Benefit Manager (PBM) commenting on this
Summary With the rate of Type II diabetes on the rise in the U.S., the pharmaceutical industry has seized the opportunity to develop new medications for patients with this incurable condition
US$ 20.09
US$ 24.23
US$ 23.52
US$ 22.50
US$ 21.61
US$ 21.26
